ELI LILLY & Co (LLY) Financial Statements (2025 and earlier)

Company Profile

Business Address LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
State of Incorp. IN
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,3642,5862,9282,4942,8293,669
Cash and cash equivalents3,2242,4602,8192,3812,6953,546
Short-term investments140126109113135123
Receivables13,07910,01411,33610,3649,1719,022
Inventory, net of allowances, customer advances and progress billings6,4826,1025,7734,9014,7994,545
Inventory6,4826,1025,7734,9014,7994,545
Prepaid expense7,1386,3495,5414,080  
Other current assets142139150   
Other undisclosed current assets    1,1684,5323,575
Total current assets:30,20425,18925,72723,00721,33220,811
Noncurrent Assets
Property, plant and equipment14,82913,62412,91411,86311,27710,546
Long-term investments and receivables2,8783,0873,0522,6922,7452,750
Long-term investments2,8783,0873,0522,6922,7452,750
Intangible assets, net (including goodwill)12,40411,70211,84610,86710,98211,160
Goodwill5,7684,9404,9404,0854,0794,073
Intangible assets, net (excluding goodwill)6,6366,7626,9076,7826,9047,087
Deferred income tax assets6,6555,6345,4774,5753,8063,407
Other noncurrent assets4,9044,7084,9904,9124,6724,488
Total noncurrent assets:41,67138,75538,27934,90933,48232,352
TOTAL ASSETS:71,87563,94464,00657,91654,81453,163
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,2643,3185,4185,6465,5924,284
Accounts payable2,9252,4742,5992,4352,4742,016
Accrued liabilities2,3398442,8203,2113,1182,268
Debt5,1621,6526,9052,2456623
Derivative instruments and hedges, liabilities   2   
Other liabilities4,2494,1993,2812,5852,2722,194
Other undisclosed current liabilities12,4479,43011,68711,52210,3909,530
Total current liabilities:27,12118,59827,29321,99818,91516,010
Noncurrent Liabilities
Long-term debt and lease obligation23,73024,56018,32117,92418,15818,881
Long-term debt, excluding current maturities23,73024,56018,32117,92418,15818,881
Liabilities, other than long-term debt7,3887,8887,5296,6866,5916,978
Accounts payable and accrued liabilities3,4974,1893,8493,4683,3313,842
Liability, pension and other postretirement and postemployment benefits1,4201,4281,4391,3121,3091,313
Other liabilities2,4712,2712,2411,9061,9521,823
Total noncurrent liabilities:31,11832,44825,84924,61024,75025,858
Total liabilities:58,23951,04653,14346,60843,66541,868
Equity
Equity, attributable to parent, including:13,56212,81210,77211,22011,06411,190
Common stock594594594594594594
Treasury stock, value(33)(33)(44)(45)(45)(45)
Additional paid in capital7,2147,0107,2507,1606,9496,793
Accumulated other comprehensive loss(4,379)(4,300)(4,327)(3,785)(3,789)(3,777)
Retained earnings13,17812,55410,31210,31010,36910,639
Other undisclosed equity, attributable to parent(3,013)(3,013)(3,013)(3,013)(3,013)(3,013)
Equity, attributable to noncontrolling interest7485928786105
Total equity:13,63612,89710,86411,30711,14911,295
TOTAL LIABILITIES AND EQUITY:71,87563,94464,00657,91654,81453,163

Income Statement (P&L) ($ in millions)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues11,3038,7689,3539,4998,3126,960
Cost of revenue
(Cost of Goods and Services Sold)
(2,170)(1,674)(1,788)(1,860)(1,807)(1,627)
Gross profit:9,1337,0957,5657,6396,5055,333
Operating expenses(5,418)(4,586)(5,178)(7,188)(4,282)(3,734)
Operating income:3,7152,5092,3884502,2231,599
Nonoperating income (expense)(198)27121(23)(37)36
Investment income, nonoperating374645494634
Net periodic defined benefits expense (reversal of expense), excluding service cost component114116115116116116
Other nonoperating income (expense)(8)29(22)(0)(13)2
Interest and debt expense(184)(180)(138)(125)(120)(103)
Income from continuing operations before equity method investments, income taxes:3,3342,3572,3713032,0661,532
Other undisclosed income (loss) from continuing operations before income taxes18418013812523(2)
Income from continuing operations before income taxes:3,5172,5362,5094272,0891,530
Income tax expense(550)(293)(319)(485)(326)(185)
Net income (loss) available to common stockholders, diluted:2,9672,2432,190(57)1,7631,345

Comprehensive Income ($ in millions)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):2,9672,2432,190(57)1,7631,345
Other comprehensive income (loss)(79)28(713)4(11)67
Comprehensive income (loss):2,8882,2701,477(54)1,7521,412
Other undisclosed comprehensive income, net of tax, attributable to parent   171   
Comprehensive income (loss), net of tax, attributable to parent:2,8882,2701,648(54)1,7521,412

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: